Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Interleukin-33 in health and disease

Interleukin-33 in health and disease Broad expression in stromal and barrier tissue renders interleukin-33 (IL-33) a ubiquitous and crucial immune modulator that shapes type 1, type 2 and regulatory immune responses. Although lacking a secretion sequence and sequestered in the nucleus, IL-33 is released and processed into highly active forms by various proteases. IL-33 contributes to cytokine networks that not only control pathogen removal but also support tissue repair mediated by group 2 innate lymphoid cells and regulatory T cells. The role of IL-33 is expected to continue to expand, modulating both protective and pathological immune responses. Delivering or blocking IL-33 is emerging as a promising therapeutic strategy for maintaining immune homeostasis and protecting against infectious and inflammatory diseases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Reviews Immunology Springer Journals

Loading next page...
 
/lp/springer-journals/interleukin-33-in-health-and-disease-mR3r9fyyCA

References (202)

Publisher
Springer Journals
Copyright
Copyright © 2016 by Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
Subject
Biomedicine; Biomedicine, general; Immunology
ISSN
1474-1733
eISSN
1474-1741
DOI
10.1038/nri.2016.95
Publisher site
See Article on Publisher Site

Abstract

Broad expression in stromal and barrier tissue renders interleukin-33 (IL-33) a ubiquitous and crucial immune modulator that shapes type 1, type 2 and regulatory immune responses. Although lacking a secretion sequence and sequestered in the nucleus, IL-33 is released and processed into highly active forms by various proteases. IL-33 contributes to cytokine networks that not only control pathogen removal but also support tissue repair mediated by group 2 innate lymphoid cells and regulatory T cells. The role of IL-33 is expected to continue to expand, modulating both protective and pathological immune responses. Delivering or blocking IL-33 is emerging as a promising therapeutic strategy for maintaining immune homeostasis and protecting against infectious and inflammatory diseases.

Journal

Nature Reviews ImmunologySpringer Journals

Published: Sep 19, 2016

There are no references for this article.